Research
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
-
* Corresponding author: Yasuhiro Ikeda ikeda.yasuhiro@mayo.edu
1 Department of Molecular Medicine, Mayo Clinic, Rochester, MN55905, USA
2 Human Cell Therapy Laboratory, Mayo Clinic, Rochester, MN 55905, USA
3 Dermatology, Mayo Clinic, Rochester, MN 55905, USA
4 Nephrology and Hypertension Research, Mayo Clinic, Rochester, MN 55905, USA
5 Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA
Stem Cell Research & Therapy 2011, 2:48 doi:10.1186/scrt89
Published: 6 December 2011Additional files
Additional file 1:
Antibodies and primer sequences. Supplementary Table 1 presenting primary and secondary antibodies used in this study, and Supplementary Table 2 presenting primer sequences.
Format: DOC Size: 80KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Supplementary Figure 1 showing patient-specific iPS cells stained with control antibodies and ADPKD iPS cells stained with isotype control mouse (Ms) IgG, rabbit (Rb) IgG, secondary antibody FITC-conjugated mouse IgG and FITC-conjugated rabbit IgG.
Format: JPEG Size: 54KB Download file
